Invitae, a leading medical genetics company, announced a partnership with BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, designed...
Fulgent Genetics, Inc, a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, announced the immediate availability of their new...
